Consequences of rpoB mutations missed by the GenoType MTBDR plus assay in a programmatic setting in South Africa.

Nomonde Ritta Mvelase Lindiwe P Cele Ravesh Singh Yeshnee Naidoo Jennifer Giandhari Eduan Wilkinson Tulio de Oliveira Khine Swe Swe-Han Koleka P Mlisana

Published in: African journal of laboratory medicine (2023)

. This led to substantial delays in the initiation of appropriate therapy. The previous tuberculosis treatment history and the high level of resistance to other anti-tuberculosis drugs suggest an accumulation of resistance.

Keyphrases

south africa
mycobacterium tuberculosis
pulmonary tuberculosis
hiv aids
high throughput
hiv positive
adverse drug
combination therapy
mesenchymal stem cells
electronic health record